ReviewCureus2021

Overview of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors for the Treatment of Non-diabetic Heart Failure Patients.

Irina Balan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.